EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Prevalence of Autoimmune Gastritis Worldwide: A Systematic Review and Meta‐Analysis

Meixuan Li, Yu Huang, Xiao Liang, Hong Lu

Helicobacter · 2025-07 · 30 (4)

DOI: 10.1111/hel.70065 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Helicobacter, online erschienen am 19.08.2025. Verfasst von Meixuan Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogene…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Gastritis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Top-Priority Medical Center Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autoimmune gastritis (AIG) is a chronic immune‐mediated disease characterized by the presence of anti‐parietal cell antibody and progressive corpus‐predominant atrophy. The global prevalence of AIG and its associated factors remain poorly understood. This study aimed to systematically estimate the prevalence of AIG worldwide and identify demographic and diagnostic factors influencing its variability.

Methods

In this systematic review and meta‐analysis, we searched Medline, Scopus, and Embase from database inception until December 7, 2024. Prevalence was pooled using a random‐effects model, and potential sources of heterogeneity were explored by subgroup analysis and meta‐regression analysis.

Results

A total of 47 studies involving 15,817 individuals were included. The global prevalence of AIG was estimated at 3.85% (95% CI: 2.94–5.04, I 2 = 99.3%). Notable geographical variation was observed, with a prevalence of 4.94% in Europe (95% CI: 3.66–6.63), 2.23% in Asia (95% CI: 1.19–4.14), 2.82% in America (95% CI: 1.48–5.31), 8.46% in Africa (95% CI: 5.58–13.14) and 8.08% in Australia (95% CI: 4.69–12.79). The prevalence was highest when diagnosed by serological antibody (5.4%, 95% CI: 3.79–7.65), followed by histology (2.71%, 95% CI: 1.68–4.36) and combined serology and histology (1.81%, 95% CI: 0.80–4.07). Meta‐regression analysis revealed a positive correlation between H. pylori infection and AIG prevalence.

Conclusions

This study estimated the global prevalence of AIG and underscored the significant geographical and methodological variability. Future studies of large‐scale are still in urgent need to standardize the diagnostic criteria and further investigate risk factors, thus enhancing the understanding and management of AIG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesGastritisHumansPrevalenceGlobal Health

Stichwörter der Autor:innen

Helicobacter pyloriautoimmune gastritisparietal cell antibodyprevalence

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao…

Förderung

  • National Natural Science Foundation of China
  • Shanghai Top-Priority Medical Center Construction Project

Zitieren

APA

Li, M., Huang, Y., Liang, X., & Lu, H. (2025). Prevalence of Autoimmune Gastritis Worldwide: A Systematic Review and Meta‐Analysis. Helicobacter, 30(4). https://doi.org/10.1111/hel.70065

Vancouver

Li M, Huang Y, Liang X, Lu H. Prevalence of Autoimmune Gastritis Worldwide: A Systematic Review and Meta‐Analysis. Helicobacter. 2025;30(4). doi:10.1111/hel.70065

BibTeX
@article{Li2025,
  author = {Li, Meixuan and Huang, Yu and Liang, Xiao and Lu, Hong},
  title = {Prevalence of Autoimmune Gastritis Worldwide: A Systematic Review and Meta‐Analysis},
  journal = {Helicobacter},
  year = {2025},
  volume = {30},
  number = {4},
  doi = {10.1111/hel.70065}
}
Kostenlos starten →